comparemela.com

Page 2 - Us Worldmeds News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

SAN DIEGO, Dec. 21, 2023 DMK Pharmaceuticals Corporation , a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid.

DMK Pharma Up 17% On Regaining Full Rights To Commercialize ZIMHI

On Thursday, DMK Pharmaceuticals Corporation (DMK) experienced a significant increase in share price, with a 17% rise, following an announcement that the company has regained full rights to commercialize ZIMHI (naloxone).

vimarsana © 2020. All Rights Reserved.